August 2017 FDA Recall Drug by Remedyrepack Inc.
D-1176-2017 - Crystallization

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on August 22, 2017 for the product Drug. The FDA reported the reason for recall as crystallization. The product was distributed in Product was distributed to one consignee in Louisiana. and the recall is currently terminated.

Recall Number: D-1176-2017

Reason for Recall
Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.
Initiated
08-22-2017
Reported
10-04-2017
Quantity
40 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to one consignee in Louisiana.
Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.

Batch or Lot Expiration Information

Lot# : a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017